Professor Robert Llewellyn Clancy AM is a leading Australian clinical immunologist and a pioneer in the field of mucosal immunology. He is known for his research and development of therapies for Chronic Obstructive Pulmonary Disease (COPD), commonly known as emphysema.
Professor Clancy developed the vaccine Broncostat at the University of Newcastle in 1985. The Broncostat vaccine reduces attacks of acute bronchitis to a degree of 90%.
Professor Clancy is Emeritus Professor at the University of Newcastle’s School of Biomedical Sciences and Pharmacy. Professor Clancy holds a B.Sc.Med (Hons)and a MB.BS (Hons) from the University of Sydney, and a PhD from Monash University. He is a Fellow of the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australia (FRCPA).